Baxter Change in Accounts Receivable 2010-2025 | BAX

Baxter change in accounts receivable for the twelve months ending June 30, 2025 was $-66M, a 146.15% decline year-over-year.

  • Baxter annual change in accounts receivable for 2024 was $-0.035B, a 7.89% decline from 2023.
  • Baxter annual change in accounts receivable for 2023 was $-0.038B, a 20.83% decline from 2022.
  • Baxter annual change in accounts receivable for 2022 was $-0.048B, a 71.76% decline from 2021.

Baxter Change in Accounts Receivable 2010-2025 | BAX

  • Baxter annual change in accounts receivable for 2024 was $-0.035B, a 7.89% decline from 2023.
  • Baxter annual change in accounts receivable for 2023 was $-0.038B, a 20.83% decline from 2022.
  • Baxter annual change in accounts receivable for 2022 was $-0.048B, a 71.76% decline from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$229B
Boston Scientific (BSX)$157.6B
Stryker (SYK)$150.8B
EssilorLuxottica (ESLOY)$144B
Medtronic (MDT)$118.3B
Lonza Group Ag (LZAGY)$50.6B
Haleon (HLN)$43.2B
ResMed (RMD)$41.8B
GE HealthCare Technologies (GEHC)$33.8B
Agilent Technologies (A)$33.6B
Koninklijke Philips (PHG)$26.8B
Terumo (TRUMY)$26.5B
Insulet (PODD)$23.4B
Zimmer Biomet Holdings (ZBH)$21.3B
Smith & Nephew SNATS (SNN)$16.3B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.1B
Bio-Rad Laboratories (BIO)$8B
Lantheus Holdings (LNTH)$3.8B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Prestige Consumer Healthcare (PBH)$3.3B
Perrigo (PRGO)$3.3B
ICU Medical (ICUI)$3.1B
Haemonetics (HAE)$2.7B
LeMaitre Vascular (LMAT)$2.2B
Acuren (TIC)$2.2B
Curaleaf Holdings (CURLF)$2.1B
QuidelOrtho (QDEL)$1.9B
Green Thumb Industries (GTBIF)$1.9B